Search results - 6 results
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
Women living with HIV have 6-times the risk of cervical cancer compared to women in the general population, and we harnessed a model platform (‘Policy1-Cervix- HIV ’) to evaluate the benefits and harms of ...
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
less effective and less cost-effective than HPV screening every 5 years. Furthermore, VIA generated more than double the number of pre-cancer treatments compared to HPV. In conclusion, primary HPV ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
rates of histologically confirmed high grade intraepithelial lesions or worse (CIN2 +) in each arm. DISCUSSION: his pilot randomised healthcare study nested in the OCCSP in Poland will assess and compare ...
Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
specimen handling Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vagina Abstract: The accuracy of high-risk human papillomavirus testing with the Xpert HPV assay on vaginal self-samples was compared ...
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
screen test positivity, triage compliance, triage positivity and treatment compliance. Test agreement between local GeneXpert and central comparator high-risk HPV (hrHPV) testing for a random set of ...
Comparison and validation of metadta for meta-analysis of diagnostic test accuracy studies.
meta-regression, and network meta-analysis of diagnostic test accuracy studies in Stata. Using data from published meta-analyses, we validate metadta by comparing and contrasting its features and output to popular ...